Vanguard Growth Index Fund Institutional Shares

This fund invests in stocks of large U.S. companies in market sectors that tend to grow more quickly than the broad market. This low-cost index fund follows a buy-and-hold approach and invests in substantially all of the stocks represented in its broad benchmark. The fund’s primary risk, apart from general stock market volatility, comes from the fact that its focus on large-capitalization growth stocks may, at times, underperform the broader stock market.With respect to 75% of its total assets, the fund may not: (1) purchase more than 10% of the outstanding voting securities of any one issuer or (2) purchase securities of any issuer if, as a result, more than 5% of the fund’s total assets would be invested in that issuer’s securities; except as may be necessary to approximate the composition of its target index. This limitation does not apply to obligations of the U.S. government or its agencies or instrumentalities.

Vanguard Growth Index Fund Institutional Shares trades as VIGIX on NASDAQ. The company is classified in Financial Services / Asset Management and reports in USD.

The current profile places the business in Asset Management. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Vanguard Growth Index Fund Institutional Shares can be compared against peers such as Vanguard Consumer Staples Index Fund Admiral Shares, Vanguard Emerging Markets Stock Index Fund Institutional Plus Shares, Vanguard Extended Market Index Fund Admiral Shares, Vanguard Real Estate Index Fund Institutional Shares, Vanguard Mid-Cap Value Index Fund Admiral Shares, Vanguard Small-Cap Growth Index Fund Admiral Shares.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $368.90B, beta of 1.24, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

VIGIX currently shows total debt of N/A and beta of 1.24. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: NPORT-P (2026-05-28 00:00:00), NPORT-P (2026-05-28 00:00:00), NPORT-P (2026-05-28 00:00:00), NPORT-P (2026-05-28 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://investor.vanguard.com/investment-products/mutual-funds/profile/vigix

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.